Business Description
Strides Pharma Science Ltd
ISIN : INE939A01011
Compare
Compare
Traded in other countries / regions
STAR.India IPO Date
2000-02-02Description
Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 1.36 | |||||
| Debt-to-EBITDA | 7.99 | |||||
| Interest Coverage | 1.45 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.79 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.5 | |||||
| 3-Year EBITDA Growth Rate | -14 | |||||
| 3-Year Book Growth Rate | -4.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.82 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.1 | |||||
| 9-Day RSI | 56.58 | |||||
| 14-Day RSI | 56.14 | |||||
| 6-1 Month Momentum % | 74.95 | |||||
| 12-1 Month Momentum % | 123.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.08 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 244.77 | |||||
| Days Sales Outstanding | 117.19 | |||||
| Days Payable | 206.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.17 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| Forward Dividend Yield % | 0.17 | |||||
| 5-Year Yield-on-Cost % | 0.17 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 2.22 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.13 | |||||
| Operating Margin % | 10.15 | |||||
| Net Margin % | -2.54 | |||||
| FCF Margin % | -1.3 | |||||
| ROE % | -4.47 | |||||
| ROA % | -1.49 | |||||
| ROIC % | 8.16 | |||||
| ROC (Joel Greenblatt) % | 4.46 | |||||
| ROCE % | 3.41 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 121.48 | |||||
| Shiller PE Ratio | 17.83 | |||||
| PS Ratio | 1.97 | |||||
| PB Ratio | 3.71 | |||||
| Price-to-Tangible-Book | 7.87 | |||||
| Price-to-Operating-Cash-Flow | 171 | |||||
| EV-to-EBIT | 87.97 | |||||
| EV-to-EBITDA | 29.66 | |||||
| EV-to-Revenue | 2.68 | |||||
| EV-to-FCF | -200.09 | |||||
| Price-to-Projected-FCF | 29.71 | |||||
| Price-to-Graham-Number | 6.63 | |||||
| Earnings Yield (Greenblatt) % | 1.13 | |||||
| FCF Yield % | -0.62 | |||||
| Forward Rate of Return (Yacktman) % | -7.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Strides Pharma Science Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 38,727.41 | ||
| EPS (TTM) (₹) | -10.95 | ||
| Beta | 0.75 | ||
| Volatility % | 38.8 | ||
| 14-Day RSI | 56.14 | ||
| 14-Day ATR (₹) | 31.669541 | ||
| 20-Day SMA (₹) | 866.4575 | ||
| 12-1 Month Momentum % | 123.84 | ||
| 52-Week Range (₹) | 346.15 - 915 | ||
| Shares Outstanding (Mil) | 91.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Strides Pharma Science Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Strides Pharma Science Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Strides Pharma Science Ltd Frequently Asked Questions
What is Strides Pharma Science Ltd(NSE:STAR)'s stock price today?
The current price of NSE:STAR is ₹872.30. The 52 week high of NSE:STAR is ₹915.00 and 52 week low is ₹346.15.
When is next earnings date of Strides Pharma Science Ltd(NSE:STAR)?
The next earnings date of Strides Pharma Science Ltd(NSE:STAR) is .
Does Strides Pharma Science Ltd(NSE:STAR) pay dividends? If so, how much?
The Dividend Yield %  of Strides Pharma Science Ltd(NSE:STAR) is 0.17% (As of Today), Highest Dividend Payout Ratio of Strides Pharma Science Ltd(NSE:STAR) was 1.27. The lowest was 0.04. And the median was 0.31. The  Forward Dividend Yield % of Strides Pharma Science Ltd(NSE:STAR) is 0.17%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers